KRAS Testing and First-Line Treatment Among Patients Diagnosed With Metastatic Colorectal Cancer Using Population Data From Ten National Program of Cancer Registries in the United States

Journal of Cancer Research & Therapy
doi 10.14312/2052-4994.2017-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Noble Research Publishers

Related search

Cetuximab in First Line Treatment of Metastatic Colorectal Cancer

Farmeconomia. Health economics and therapeutic pathways
2012English

PCN70 Cost-Effectiveness of Cetuximab and Bevacizumab in the First-Line Treatment of Metastatic Colorectal Cancer (mCRC) for Patients With Kras Wild-Type Tumours in the United Kingdom

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Reply: Capecitabine and Bevacizumab as First-Line Treatment in Elderly Patients With Metastatic Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2010English

Prevalence of KRAS, BRAF, PI3K and EGFR Mutations Among Asian Patients With Metastatic Colorectal Cancer

Oncology Letters
Cancer ResearchOncology
2015English

Capecitabine and Irinotecan as First- Line Chemotherapy for Patients With Metastatic Colorectal Cancer

Journal of IMAB - Annual Proceeding (Scientific Papers)
Dentistry
2011English

Metastatic Colorectal Cancer First-Line Treatment With Bevacizumab: The Impact of K-Ras Mutation

OncoTargets and Therapy
OncologyPharmacology
2013English

Real World Treatment Patterns of Patients With Ovarian Cancer Receiving First Line Chemotherapy in the United States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

New Strategies for Treatment of KRAS Mutant Metastatic Colorectal Cancer

Clinical Cancer Research
Cancer ResearchOncology
2010English

KRAS Mutation Analysis of Single Circulating Tumor Cells From Patients With Metastatic Colorectal Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy